id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-316498-f43apjul	Karlsson, Jan Olof G	May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?	2020-10-10		.txt	text/plain	1931	102	42	The Manganese diPyridoxyL EthylDiamine (MnPLED)-type mangafodipir (manganese dipyridoxyl diphosphate—MnDPDP), a magnetic resonance imaging (MRI) contrast agent that possesses MnSOD mimetic activity, has shown promising results in various forms of inflammation, in preclinical as well as clinical settings. The Manganese diPyridoxyL EthylDiamine (MnPLED)-type mangafodipir (manganese dipyridoxyl diphosphate-MnDPDP), a magnetic resonance imaging (MRI) contrast agent that possesses MnSOD mimetic activity, has shown promising results in various forms of inflammation, in preclinical as well as clinical settings. Intravenously administration of mangafodipir will, in contrast to INO [1] : "Everyone will be exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and most people will become infected; the disease is known as COVID-19. When it comes to mangafodipir, its combined MnSOD mimetic and redox metal binding activity may be of particular importance when attacking the inflammatory storm in SARS-CoV-2 patients.	./cache/cord-316498-f43apjul.txt	./txt/cord-316498-f43apjul.txt